NatureWise Biotech & Medicals Corporation (TPEX:4732)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.80
+0.95 (5.64%)
Aug 26, 2026, 1:47 PM CST

TPEX:4732 Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
174.62176.77224.32160.14228.59249.8
Revenue Growth
-1.21%-21.20%40.08%-29.94%-8.49%-18.61%
Gross Profit
81.2685.7120.287.38129.93146.19
Operating Income
-170.19-106.87-12.023.4326.3526.98
Net Income
-133.68-92.280.910.1230.0230.81
Earnings Per Share
-2.77-1.890.020.200.610.62
EPS Growth
---90.90%-67.17%-1.75%-53.03%

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Dec '22 Dec '21
Taiwan
172.1222.21160.14228.02249.77
Mainland China
4.52.11---
Other
0.17----
Total
176.77224.32160.14228.59249.8

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
409.13470.39614.73475.26493.98497.87
Total Debt
29.111.493.47.782.76.64
Net Cash (Debt)
380.03458.9611.33467.48491.28491.23
Net Cash Growth
-17.19%-24.93%30.77%-4.84%0.01%4.65%
Net Cash Per Share
7.869.4212.279.379.939.96

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-188-111.74-2.862.213.8533.72
Capital Expenditures
-0.24-0.84-0.12-0.31--
Free Cash Flow
-188.24-112.58-2.9161.913.8533.72
Free Cash Flow Growth
---346.81%-58.92%-38.25%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.53%48.48%53.58%54.56%56.84%58.52%
Operating Margin
-97.46%-60.46%-5.36%2.14%11.53%10.80%
Pretax Margin
-91.98%-57.44%-1.63%6.20%13.13%12.27%
Profit Margin
-76.55%-52.20%0.40%6.32%13.13%12.33%
FCF Margin
-107.80%-63.69%-1.30%38.65%6.06%13.50%

Dividends

Fiscal YearFY 2023FY 2022FY 2021
Period EndingDec '23 Dec '22 Dec '21
Dividend Per Share
0.2000.5000.300
Dividend Per Share Growth
-60.00%66.67%218.13%
Dividend Yield
0.84%1.66%0.69%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--1371.24132.7257.8782.24
P/FCF Ratio
---21.70125.4275.14
PS Ratio
4.575.665.488.397.6010.14